XML 17 R1.htm IDEA: XBRL DOCUMENT v3.25.1
Document and Entity Information
 12 Months Ended
Dec. 31, 2024
shares
Document Information [Line Items]  
Document Type 20-F
Document Registration Statement false
Document Annual Report true
Document Period End Date Dec. 31, 2024
Document Transition Report false
Document Shell Company Report false
Entity File Number 001-35773
Entity Registrant Name RedHill Biopharma Ltd.
Entity Incorporation, State or Country Code L3
Entity Address, Address Line One 21 Ha’arba’a Street
Entity Address, City or Town Tel Aviv
Entity Address, Postal Zip Code 6473921
Entity Address, Country IL
Entity Common Stock, Shares Outstanding 12,899,831,000
Entity Well-known Seasoned Issuer No
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company false
ICFR Auditor Attestation Flag false
Document Financial Statement Error Correction [Flag] false
Document Accounting Standard International Financial Reporting Standards
Entity Shell Company false
Auditor Name Kesselman & Kesselman
Auditor Location Tel-Aviv, Israel
Auditor Firm ID 1309
Entity Central Index Key 0001553846
Current Fiscal Year End Date --12-31
Document Fiscal Year Focus 2024
Document Fiscal Period Focus FY
Amendment Flag false
ADS  
Document Information [Line Items]  
Title of 12(b) Security American Depositary Shares, each representing ten thousand (10,000) Ordinary Shares (1)
Trading Symbol RDHL
Security Exchange Name NASDAQ
Ordinary shares  
Document Information [Line Items]  
Title of 12(b) Security Ordinary Shares, par value NIS 0.01 per share (2)
Business contact  
Document Information [Line Items]  
Contact Personnel Name Razi Ingber
Entity Address, Address Line One 21 Ha’arba’a Street
Entity Address, City or Town Tel Aviv
Entity Address, Postal Zip Code 6473921
Entity Address, Country IL
City Area Code 972
Local Phone Number 3-541-3131
Contact Personnel Fax Number 972-3-541-3144